Response Genetics, Inc. Announces Third Quarter 2013 Financial Results
November 07, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. to Release Third Quarter 2013 Financial Results and Host Conference Call on November 7, 2013
October 31, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Oct. 31, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Payor Contract With Fortified Provider Network
October 02, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Oct. 2, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Contract With Three Rivers Provider Network
September 25, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces $1.9 Million Registered Direct Offering
September 20, 2013 08:45 ET
|
Response Genetics, Inc.
LOS ANGELES, Sept. 20, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, today announced that it...
Response Genetics, Inc. Acquires Proprietary FDA-Cleared and Medicare-Reimbursed Test and All Associated Assets for Difficult to Diagnose Solid Tumors
August 26, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Aug. 26, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, today announced the...
Response Genetics, Inc. Announces Contract With MultiPlan, Inc.
August 12, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Aug. 12, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. Announces Second Quarter 2013 Financial Results
August 08, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, Aug. 8, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics, Inc. to Release Second Quarter 2013 Financial Results and Host Conference Call on August 8, 2013
July 31, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, July 31, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
Response Genetics Renews Agreement With Taiho Pharmaceutical Co., Ltd. to Provide Molecular Analyses for Cancer
July 17, 2013 07:00 ET
|
Response Genetics, Inc.
LOS ANGELES, July 17, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...